52 related articles for article (PubMed ID: 15471831)
1. Clinical usefulness of 18F-FDG PET in nasopharyngeal carcinoma patients with questionable MRI findings for recurrence.
Ng SH; Joseph CT; Chan SC; Ko SF; Wang HM; Liao CT; Chang YC; Lin WJ; Fu YK; Yen TC
J Nucl Med; 2004 Oct; 45(10):1669-76. PubMed ID: 15471831
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of pre-treatment [
Dong Z; Wang GY; Dai DY; Qin GJ; Tang LL; Xu C; Ma J
BMC Cancer; 2024 Apr; 24(1):466. PubMed ID: 38622555
[TBL] [Abstract][Full Text] [Related]
3. Use of 18F-FDG PET/MRI as an Initial Staging Procedure for Nasopharyngeal Carcinoma.
Cao C; Fang Y; Yu B; Xu Y; Qiang M; Tao C; Huang S; Chen X
J Magn Reson Imaging; 2024 Mar; 59(3):922-928. PubMed ID: 37256732
[TBL] [Abstract][Full Text] [Related]
4. FDG PET/CT Demonstrated Unilateral Striatum Hypometabolism in a Case of Advanced Nasopharyngeal Cancer.
Lu XP; Chen AC; Wu MC; Tseng HC; Kao PF
Clin Nucl Med; 2024 Jan; 49(1):104-105. PubMed ID: 37976532
[TBL] [Abstract][Full Text] [Related]
5. The impact of the COVID-19 pandemic on nasopharyngeal carcinoma extent at FDG PET/MR staging: The NPCOVIPET study.
Cao C; Xu Y; Qiang M; Tao C; Huang S; Wang L; Chen X
Head Neck; 2023 Aug; 45(8):1979-1985. PubMed ID: 37260311
[TBL] [Abstract][Full Text] [Related]
6. [18F]-FDG PET and MRI radiomic signatures to predict the risk and the location of tumor recurrence after re-irradiation in head and neck cancer.
Beddok A; Orlhac F; Calugaru V; Champion L; Ala Eddine C; Nioche C; Créhange G; Buvat I
Eur J Nucl Med Mol Imaging; 2023 Jan; 50(2):559-571. PubMed ID: 36282298
[TBL] [Abstract][Full Text] [Related]
7. Ultra-low-dose in brain 18F-FDG PET/MRI in clinical settings.
Soret M; Maisonobe JA; Desarnaud S; Bergeret S; Causse-Lemercier V; Berenbaum A; Rozenblum L; Habert MO; Kas A
Sci Rep; 2022 Sep; 12(1):15341. PubMed ID: 36097015
[TBL] [Abstract][Full Text] [Related]
8. Recurrent non-rheumatic streptococcal myocarditis: 18F-FDG PET/CMR findings.
Baltzinger P; El Ghannudi S; Germaini M; Von Hunolstein JJ; Zeyons F; Imperiale A
QJM; 2024 Jan; ():. PubMed ID: 38273703
[TBL] [Abstract][Full Text] [Related]
9. Taming the tiger: Insights into sarcoid myositis through 18F-FDG PET/MRI imaging.
Kaseb A; Giannini M; Dramé B; Willaume T; Meyer A; Imperiale A
QJM; 2024 Apr; ():. PubMed ID: 38608186
[No Abstract] [Full Text] [Related]
10. Artificial intelligence aided precise detection of local recurrence on MRI for nasopharyngeal carcinoma: a multicenter cohort study.
OuYang PY; He Y; Guo JG; Liu JN; Wang ZL; Li A; Li J; Yang SS; Zhang X; Fan W; Wu YS; Liu ZQ; Zhang BY; Zhao YN; Gao MY; Zhang WJ; Xie CM; Xie FY
EClinicalMedicine; 2023 Sep; 63():102202. PubMed ID: 37680944
[TBL] [Abstract][Full Text] [Related]
11. Surveillance tools for detection of recurrent nasopharyngeal carcinoma: An evidence-based review and recommendations.
Thamboo A; Tran KH; Ye AX; Shoucair I; Jabarin B; Prisman E; Garnis C
World J Otorhinolaryngol Head Neck Surg; 2022 Sep; 8(3):187-204. PubMed ID: 36159905
[TBL] [Abstract][Full Text] [Related]
12. A head-to-head comparison of
Qin C; Liu F; Huang J; Ruan W; Liu Q; Gai Y; Hu F; Jiang D; Hu Y; Yang K; Lan X
Eur J Nucl Med Mol Imaging; 2021 Sep; 48(10):3228-3237. PubMed ID: 33609152
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of the post-radiotherapy
Jeong Y; Jung IH; Kim JS; Chang SK; Lee SW
Br J Radiol; 2019 Oct; 92(1102):20180045. PubMed ID: 30102562
[TBL] [Abstract][Full Text] [Related]
14. Head-to-head comparison between
Heimburger C; Veillon F; Taïeb D; Goichot B; Riehm S; Petit-Thomas J; Averous G; Cavalcanti M; Hubelé F; Chabrier G; Namer IJ; Charpiot A; Imperiale A
Eur J Nucl Med Mol Imaging; 2017 Jun; 44(6):979-987. PubMed ID: 28050631
[TBL] [Abstract][Full Text] [Related]
15. The clinical utility of FDG PET/CT among solid organ transplant recipients suspected of malignancy or infection.
Wareham NE; Lundgren JD; Da Cunha-Bang C; Gustafsson F; Iversen M; Johannesen HH; Kjær A; Rasmussen A; Sengeløv H; Sørensen SS; Fischer BM
Eur J Nucl Med Mol Imaging; 2017 Mar; 44(3):421-431. PubMed ID: 27838763
[TBL] [Abstract][Full Text] [Related]
16. Meta-analysis of diagnostic value of 18F-FDG PET or PET/CT for detecting lymph node and distant metastases in patients with nasopharyngeal carcinoma.
Shen G; Zhang W; Jia Z; Li J; Wang Q; Deng H
Br J Radiol; 2014 Dec; 87(1044):20140296. PubMed ID: 25348201
[TBL] [Abstract][Full Text] [Related]
17. Early detection of nasopharyngeal carcinoma.
Tabuchi K; Nakayama M; Nishimura B; Hayashi K; Hara A
Int J Otolaryngol; 2011; 2011():638058. PubMed ID: 21716698
[TBL] [Abstract][Full Text] [Related]
18. Current treatment options for recurrent nasopharyngeal cancer.
Suárez C; Rodrigo JP; Rinaldo A; Langendijk JA; Shaha AR; Ferlito A
Eur Arch Otorhinolaryngol; 2010 Dec; 267(12):1811-24. PubMed ID: 20865269
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive imaging of residual/ recurrent nasopharyngeal carcinoma using whole-body MRI at 3 T compared with FDG-PET-CT.
Ng SH; Chan SC; Yen TC; Liao CT; Chang JT; Ko SF; Wang HM; Lin CY; Chang KP; Lin YC
Eur Radiol; 2010 Sep; 20(9):2229-40. PubMed ID: 20393714
[TBL] [Abstract][Full Text] [Related]
20. Advantages and pitfalls of 18F-fluoro-2-deoxy-D-glucose positron emission tomography in detecting locally residual or recurrent nasopharyngeal carcinoma: comparison with magnetic resonance imaging.
Chan SC; Ng SH; Chang JT; Lin CY; Chen YC; Chang YC; Hsu CL; Wang HM; Liao CT; Yen TC
Eur J Nucl Med Mol Imaging; 2006 Sep; 33(9):1032-40. PubMed ID: 16622711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
